Functional ephrin-B2 expression for promotive interaction between arterial and venous vessels in postnatal neovascularization

Circulation

Volumn 111, Issue 17, 2005, Pages 2210-2218

  Hayashi, Shin Ichiro ^a   Asahara, Takayuki ^a   Masuda, Haruchika ^a   Isner, Jeffrey M ^a   Losordo, Douglas W ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Endothelial cells; Ephrin B2; Ischemia; Postnatal

Indexed keywords

ANGIOPOIETIN 1; BASIC FIBROBLAST GROWTH FACTOR; EPHRIN B2; SCATTER FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY; ARTERY ENDOTHELIUM; ARTICLE; LIMB ISCHEMIA; MALE; MOUSE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; UPREGULATION; VEIN;

ANIMALS; ARTERIES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; EPHRIN-B2; GROWTH SUBSTANCES; HINDLIMB; HUMANS; ISCHEMIA; LIMBUS CORNEAE; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; UP-REGULATION; VEINS;

EID: 18244382791     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000163566.07427.73     Document Type: Article

References (50)

1. Ware JA, Simons M. Angiogenesis in ischemic heart disease. Nat Med. 1997;3:158-164.
2. Forkman J. Angiogenesis in cancer, vascular, rheumatoid and disease. Nat Med. 1995;1:27-31.
3. Hanahan D. Signaling vascular morphogenesis and maintenance. Science. 1997;277:48-50.
4. Gale NW, Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 1999;13:1055-1066.
5. Risaw W. Mechanism of angiogenesis. Nature. 1997;386:671-674.
6. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KW, Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439-442.
7. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercg C, Pawling J, Moons L, Collen D, Risau W, Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996;380:435-442.
8. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 1995;376:62-66.
9. Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 1995;376:66-70.
10. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 1996;87:1171-1180.
11. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. Distinct roles of the receptor tyrosine kinase Tie-1 and Tie-2 in blood vessel formation. Nature. 1995;376:70-74.
12. Dumont DJ, Fong GH, Puri MC, Gradwohl G, Alitalo K, Breitman ML. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn. 1995;203:80-92.
13. Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J. 1995;23:5884-5891.
14. Takakura N, Huang XL, Naruse T, Hamaguchi I, Dumont DJ, Yancopoulos GD, Suda T. Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity. 1998;5:677-686.
15. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. Science. 1997;277:55-60.
16. Holder N, Klein R. Eph receptors and ephrins: effectors of morphogenesis. Development. 1999;10:2033-2044.
17. Flanagan JG, Vanderhaeghen P. The ephrins and Eph receptors in neural development. Annu Rev Neurosci. 1998;21:309-345.
18. Wang HU, Anderson DJ. EPH family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth. Neuron. 1997;18:383-396.
19. Stein E, Lane AA, Cerretti DP, Schoecklmann HO, Schroff AD, Van Etten RL, Daniel TO. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment and assembly responses. Genes Dev. 1998;12:667-678.
20. Bennett BD, Zeigler FC, Gu Q, Fendly B, Goddard AD, Gillett N, Matthews W. Molecular cloning of a ligand for the EPH-related receptor protein-tyrosine kinase Htk. Proc Natl Acad Sci U S A. 1995;92:1866-1870.
21. Bergemann AD, Cheng HJ, Brambilla R, Klein R, Flanagan JG. ELF-2, a new member of the EPH ligand family, is segmentally expressed in mouse embryo in the region of the hindbrain and newly forming somites. Mol Cell Biol. 1995;15:4921-4929.
22. Wang HU, Chen ZF, Anderson DJ. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell. 1998;93:741-753.
23. Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsh U, Risau W, Klein R. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 1999;13:295-306.
24. Gerety SS, Wang HU, Chen ZF, Anderson DJ. Symmetrical mutant phenotypes of receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell. 1999;4:403-414.
25. Shin D, Garcia-Cardena G, Hayashi S, Gerety S, Asahara T, Stavrakis G, Isner J, Folkman I, Gimbrone MA Jr, Anderson DJ. Expression of ephrin-B2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev Biol. 2001;230:139-150.
26. Gale NW, Baluk P, Pan L, Kwan M, Holash J, DeChiara TM, Mcdonald DM, Yancopoulos GD. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial smooth-muscle cells. Dev Biol. 2001;230:151-160.
27. Holland SJ, Gale NW, Mbamalu G, Yancopoulos GD, Henkemeyer M, Pawson T. Bidirectional signaling through the EPH-family receptor Nuk and its transmembrane ligands. Nature. 1996;383:722-725.
28. Bruckner K, Pasquale EB, Klein R. Tyrosine phosphorylation of transmembrane ligands for EPH receptors. Science. 1997;275:1640-1643.
29. Huynh-Do U, Stein E, Lane AA, Cerretti DP, Daniel TO. Surface densities of ephrin-B1 determine EphB1-coupled activation of cell attachment through αvβ3 and α5β1 and integrins. EMBO J. 1999;18: 2165-2173.
30. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM. A mouse model of angiogenesis. Am J Pathol. 1998;152:1667-1679.
31. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, Isner JM. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101:2567-2578.
32. Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ. A model of angiogenesis in the mouse cornea. Invest Opthalmol Vis Sci. 1996;37:1625-1632.
33. Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD, Isner JM. Tie-2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF induced postnatal neovascularization. Circ Res. 1998;83:233-240.
34. Torres R, Firestein BL, Dong H, Staudinger J, Olson EN, Huganir RL, Bredt DS, Gale NW, Yancopoulos GD. PDZ protein bind, cluster, and synaptically colocalize with EPH receptors and their ephrin ligands. Neuron. 1998;21:1453-1463.
35. Chong LD, Park EK, Latimer E, Friesel R, Daar IQ. Fibroblast growth factor receptor-mediated rescue of x-ephrin B1-induced cell dissociation in xenopus embryo. Mol Cell Biol. 2000;20:724-734.
36. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JM, Isner JM. Therapeutic angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments revascularization in rabbit ischemic hindlimb model. J Clin Invest. 1994;93:662-670.
37. Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, Symes JF. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischemic limb. Lancet. 1996;348:370-374.
38. Harada K, Grossman W, Friedman M, Edelman ER, Prasad PV, Keighley CS, Manning WJ, Sellke FW, Simons M. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest. 1994;94:623-630.
39. Morishita R, Nakamura S, Hayashi S, Taniyama Y, Moriguchi A, Nagano T, Taiji M, Noguchi H, Takeshita S, Matsumoto K, Nakamura T, Higaki J, Ogihara T. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension. 1999;33:1379-1384.
40. Rohan RM, Fernandez A, Udagawa T, Yuan J, D'Amato RJ. Genetic heterogeneity of angiogenesis in mice. FASEB J. 2000;14:871-876.
41. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science. 1999;286;2511-2514.
42. Lawson ND, Vogel AM, Weinstein BM. Sonic hedgehog and vascular endothelial growth factor act upstream of notch pathway during arterial endothelial differentiation. Dev Cell. 2002;3:127-136.
43. Mukouyama YS, Shin D, Britsch S, Taniguchi M, Anderson DJ. Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell. 2002;109:693-705.
44. Helbling PM, Sulnier DM, Brandi AW. The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in xenopus laevis. Development. 2000;127:269-278.
45. Mellitzer G, Xu Q, Wilkinson DG. Eph receptors and ephrins restrict cell intermingling and communication. Nature. 1999;400:77-80.
46. Yancopoulos GD, Klagsburn M, Folkman J. Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell. 1998;93:661-664.
47. Steinle JJ, Meininger CJ, Forough R, Wu G, Wu MH, Granger HJ. Eph B4 receptor signaling mediates endothelial cell migration and proliferation via PI3K pathway. J Biol Chem. 2002;277:43830-43835.
48. Cowan CA, Yokoyama N, Saxena A, Chumley MJ, Silvany RE, Baker LA, Srivastava D, Henkemeyer M. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development. Dev Biol. 2004;271:263-271.
49. Zhang X, Takakura N, Oike Y, Inada T, Gale N, Yancopoulos GD, Suda T. Stromal cells expressing ephrin-B2 promoting the growth and sprouting of ephrin-B2+ endothelial cells. Blood. 2001;98:1028-1037.
50. Kim I, Ryu YS, Kwak HJ, Ahn SY, Oh J, Yancopoulos GD, Gale NW, Koh GY. EphB ligand, ephrin-B2, suppresses the VEGF- and angiopoietin 1- induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells. FASEB J. 2002;16:1126-1128.